Blockade of ICAM-1/LFA-1 interaction prevents the tolerance induction by anti-CD45-RB and mice deficient in either ICAM-1 or LFA-1 reject their graft even when they are treated with anti-CD45-RB (39). This evidence concerns the gene ICAM1 and retinoblastoma.